Attitudes, knowledge and behaviour of smokers from nine European countries / Karl Fagerström ([2002])

Public Titre : Attitudes, knowledge and behaviour of smokers from nine European countries Type de document : document graphique à deux dimensions Auteurs : Karl Fagerström, Auteur ; M. Johnson, Auteur Editeur : GlaxoSmithKline Année de publication : [2002] Note générale : references: 1 Boyle, et al. Eur J Public Health 2000; 10(suppl.3):5-14. 2 Fagerström, et al. Lung Cancer 2001; 32(1):1-5 Langues : Anglais (eng) Langues originales : Anglais (eng) Catégories : [DIVERS] type de document:affiche [TABAC] étude:enquête:questionnaire [TABAC] étude:épidémiologie:milieu socio-économique Index. décimale : TA 0.4 Évaluations, enquêtes et questionnaire Résumé : During 2002, 2729 smokers from nine countries; Denmark, france, Germany, Ireland, Italy, The netherlands, Poland, Sweden and United Kingdom, were questionned about their attitudes, knowledge and behaviour towards smoking. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8188

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 003389	TA 0.4 FAG A	Affiche	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy / David J.K. Balfour (2000)  

Public Titre : Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy : a status report Type de document : document électronique Auteurs : David J.K. Balfour, Auteur ; Neal L. Benowitz, Auteur ; Karl Fagerström, Auteur ; M. Kunze, Auteur ; U. Keil, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2000 Collection : European Respiratory Journal num. 21 Importance : p.438-445 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotinique [TABAC] tabagisme:dépendance tabagique:dépendance pharmacologique [TABAC] tabagisme:évaluation du tabagisme:test de dépendance à la nicotine Index. décimale : TA 4.2.2.1 Dépendance à la nicotine Résumé : Tobacco use is a global health care problem. Repetitive exposure to nicotine produces neuroadaptation resulting in nicotine dependence. Cigarette smoking is particularly addictive due to the repeated delivery of bolus doses of nicotine to the bloodstream. Although compulsive tobacco use is sustained by nicotine addiction, it is the toxic combustion products in tobacco smoke such as carbon monoxide and oxidant gases that adversely affect the cardiovascular system. Smoking cessation produces significant health benefits and is a very cost-effective intervention. Evidence that nicotine is the addictive component of tobacco provides the rationale for using nicotine replacement therapy to aid cessation. Nicotine replacement therapy doubles successful smoking cessation rates and evidence-based guidelines for the treatment of tobacco addiction recommend routine use of nicotine replacement therapy, particularly in heavily dependent smokers. Success rates of up to 40% can be achieved in specialist clinics. Despite early concerns regarding the safety of nicotine replacement therapy in smokers with heart disease, it is now clear that the health risks of using nicotine replacement therapy to assist such patients to stop, or significantly reduce, smoking far outweigh any treatment-related risks. En ligne : https://doi.org/10.1053/euhj.1999.1949 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10348

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Introducing oral tobacco for tobacco harm reduction / Yves Martinet (2007)  

Public Titre : Introducing oral tobacco for tobacco harm reduction : what are the main obstacles ? Type de document : texte imprimé Auteurs : Yves Martinet, Auteur ; A. Bohadana, Auteur ; Karl Fagerström, Auteur Editeur : Melbourne School of Population and Global Health Euan Lawson Année de publication : 2007 Collection : Harm Reduction Journal num. 4 (17) Importance : 6 p. Langues : Anglais (eng) Catégories : [TABAC] prévention:stratégie:réduction du risque [TABAC] tabagisme:évaluation du tabagisme:test médical Index. décimale : TA 5.8 Réduction des risques Résumé : With the number of smokers worldwide currently on the rise, the regular failure of smokers to give up their tobacco addiction, the direct role of smoke (and, to a much lesser extent, nicotine) in most tobacco-related diseases, and the availability of less toxic (but still addictive) oral tobacco products, the use of oral tobacco in lieu of smoking for tobacco harm reduction (HR) merits assessment. Instead of focusing on the activity itself, HR focuses on the risks related to the activity. Currently, tobacco HR is controversial, generally not discussed, and consequently, poorly evaluated. In this paper, we try to pinpoint some of the main reasons for this lack of interest or reluctance to carry out or fund this type of research. In this paper we deal with the following issues: the status of nicotine in society, the reluctance of the mainstream anti-tobacco lobby toward the HR approach, the absence of smokers from the debate, the lack of information disseminated to the general population and politicians, the need to protect young people, the role of physicians, the future of HR research, and the role of tobacco companies. En ligne : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169217/ Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2820

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Management of smoking cessation in patients with psychiatric disorders / Karl Fagerström (2009)  

Public Titre : Management of smoking cessation in patients with psychiatric disorders Type de document : texte imprimé Auteurs : Karl Fagerström, Auteur ; Henri-Jean Aubin, Auteur Editeur : Abingdon [Angleterre] : Taylor & Francis Group Année de publication : 2009 Collection : Current medical research and opinion, ISSN 0300-7995 num. 25:2 Importance : p. 511-518 Langues : Anglais (eng) Catégories : [DIVERS] discipline médicale, paramédicale et scientifique:médecine:médecine spécialisée:psychiatrie [TABAC] chimie du tabac:constituant:alcaloïde:nicotine [TABAC] prévention:santé:santé mentale [TABAC] sevrage tabagique Index. décimale : TA 6.2 Méthodes individuelles Résumé : BACKGROUND: There is a close relationship between tobacco smoking and psychiatric disorders, and a higher proportion of individuals with mental health conditions smoke compared with the general population. Due to the increased smoking prevalence in this population, patients with psychiatric conditions are at greater risk of smoking-related morbidity and mortality and experience detrimental effects on their quality of life. However, while the majority of individuals with a history of mental health conditions appreciate that smoking is detrimental to their health, they are less likely to quit smoking and have a lower success rate during quit attempts compared with the general population. SCOPE: Peer-reviewed articles were identified from PubMed using the inclusive date-range of 1990 - October 2008 and the search terms; depression, mental health, psychiatric disorders, schizophrenia, and smoking cessation. Articles were selected from the search results to provide a general overview of some of the main issues for smokers with psychiatric disorders in general and specifically, those with schizophrenia and depression. The evidence from smoking cessation trials within these populations was also reviewed. FINDINGS: Nicotine has some positive effects on symptoms of psychiatric disorders and it has been proposed that patients with mental health conditions may smoke as a form of self-medication. Further, several studies have shown that some symptoms of psychiatric disorders may be exacerbated by nicotine withdrawal. Therefore, attempts to quit smoking pose additional problems to patients with mental health problems. CONCLUSION: Traditional programmes for smoking cessation may not always be suitable for psychiatric patients due to their neuropsychological profile. Preliminary evidence suggests that more flexible, open-ended, combination approaches of pharmacotherapy and counselling may be more successful. In addition, identification and treatment of nicotine addiction remains very low in patients with mental health conditions and far more needs to be done to raise the awareness and ability of psychiatrists to diagnose and treat patients with nicotine problems. En ligne : https://pubmed.ncbi.nlm.nih.gov/19192999/ Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8095

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 005644	TA 6.2 FAG M	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Pharmacological interventions for the treatment of smokeless tobacco use / Jon O. Ebbert (2012)

Public Titre : Pharmacological interventions for the treatment of smokeless tobacco use Type de document : texte imprimé Auteurs : Jon O. Ebbert, Auteur ; Karl Fagerström, Auteur Editeur : Adis International Année de publication : 2012 Collection : CNS Drugs, ISSN 1172-7047 num. Vol. 26 Importance : 10 p. Présentation : tab. Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:bupropion [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotinique [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline Index. décimale : TA 6.2.3 Approche pharmacologique Résumé : Smokeless tobacco (SLT) is used in a variety of forms throughout the world. Long-term SLT use is associated with adverse health consequences. Effective pharmacotherapies are needed to treat SLT users who want to achieve tobacco abstinence. In the current review, we discuss the pharmacological interventions identified in a recent meta-analysis of interventions for SLT users, with inclusion of additional articles identified by searching PubMed up to August 2011. Nicotine replacement therapy (NRT) has been demonstrated to increase short-term tobacco abstinence rates and to alleviate craving and withdrawal symptoms among SLT users trying to quit. Bupropion sustained release has been shown to decrease craving and attenuate post-cessation weight gain among SLT users trying to quit. Varenicline is the only available medication demonstrated to increase long-term (≥6 months) tobacco abstinence rates among SLT users. Overall, findings from studies investigating pharmacotherapies for SLT users have been relatively disappointing. SLT reduction interventions may hold some promise for increasing abstinence rates among SLT users not interested in quitting. Additional investigations of higher dose NRT and combination pharmacotherapy are needed to advance the treatment of SLT users. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7959

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 005500	TA 6.2.3 EBB P	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Time to first cigarette / Karl Fagerström (2003)

Public Titre : Time to first cigarette : the best single indicator of tobacco dependance? Type de document : texte imprimé Auteurs : Karl Fagerström, Auteur Editeur : Scopus Année de publication : 2003 Collection : Monaldi archives for chest disease num. 59 (1) Importance : p.93-94 Langues : Anglais (eng) Catégories : [TABAC] étude:recherche [TABAC] tabagisme:dépendance tabagique [TABAC] tabagisme:habitude tabagique Index. décimale : TA 4.2 Dépendance tabagique Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2972

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 001604	TA 4.2 FAG T	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Would alternate tobacco products use be better than smoking ? / Yves Martinet (2006)

Public Titre : Would alternate tobacco products use be better than smoking ? Type de document : texte imprimé Auteurs : Yves Martinet, Auteur ; A. Bohadana, Auteur ; Karl Fagerström, Auteur Editeur : National cancer institute Année de publication : 2006 Collection : Lung Cancer Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée [TABAC] tabagisme:effet du tabac:toxicité [TABAC] tabagisme:évaluation du tabagisme:test médical Index. décimale : TA 1.2 Tabac non fumé Résumé : Tobacco use is dominated by cigarette smoking. Most toxicity due to cigarette smoking is related to the burning process. Several observations suggest that unburned or oral tobacco is less harmful than cigarette smoking. Up to now, physicians have advised a policy based on two ideas: (i) young people should not start smoking and (ii) the only choice for smokers is to quit. However, numerous smokers cannot or do not want to give up eventually, one out of two lifelong smokers will die from smoke-related diseases. Thus, it is legitimate to ask if alternate nicotine containing product use would be better than cigarette smoking and limit the tobacco death toll. However, the logic leading to the concept of tobacco harm reduction (THR) turns out to be much more complex than it looks at a first glance. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2844

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 002616	TA 1.2 MAR W	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !